Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 166 


 
CASE REPORT Table of Contents   
Year : 2008  |  Volume : 14  |  Issue : 2  |  Page : 80-82
Intra-abdominal manifestations of von Recklinghausen's neurofibromatosis


Yash Diagnostic Center, Yash Hospital and Research Center, Civil Lines, Kanth Road, Moradabad, India

Click here for correspondence address and email

Date of Submission07-Jul-2007
Date of Acceptance13-Aug-2007
 

   Abstract 

Neurofibromatosis type-1 (NF1), also known as von Recklinghausen disease, is a common autosomal dominant condition with an approximate incidence of one per 3000 births. NF1 involves multiple systems of the body. Abdominal involvement occurs in the form of neurofibroma and tumour growth in the liver, mesentery, retroperitoneum, gastric and bowel. Gastrointestinal neoplasms have a reported occurrence of 2-25%. Two cases are reported herein as well as a review of the literature of the intra-abdominal manifestations of NF1, including a discussion on the radiological appearance and diagnosis. The article provides an insight into the intriguing variety of clinical problems that such patients may present.

Keywords: von Recklinghausen, neurofibroma, gastric outlet obstruction

How to cite this article:
Rastogi R. Intra-abdominal manifestations of von Recklinghausen's neurofibromatosis. Saudi J Gastroenterol 2008;14:80-2

How to cite this URL:
Rastogi R. Intra-abdominal manifestations of von Recklinghausen's neurofibromatosis. Saudi J Gastroenterol [serial online] 2008 [cited 2019 Nov 14];14:80-2. Available from: http://www.saudijgastro.com/text.asp?2008/14/2/80/39623


Neurofibromatosis (NF) is an autosomal dominant disorder that can involve any organ system. NF is not a single entity but a group of heterogeneous multisystemic neurocutaneous disorders. There are two distinct types: neurofibromatosis type-1 (NF1) or von Recklinghausen disease, which affects 85% of patients, and neurofibromatosis type-2 (NF2) or bilateral acoustic neuromas/schwannomas, which affects 10% of patients. Abdominal involvement in patients with NF1 has been described in the form of neurofibromas within the liver, mesentery, retroperitoneum and gastrointestinal (GI) tract. Large-bowel intussusception has also been reported. Small-bowel leiomyomas, adenocarcinomas with neuroendocrine function, GI tract vasculopathy, GI tract bleeding, pseudo-obstruction and protein-losing enteropathy also may occur.


   Case Reports Top


Two patients of NF1 with different sets of complaints were referred to our department for computed tomography (CT) scan of the abdomen.

Case 1

A 35-year-old male patient with a 5-6-month history of vague, intermittent abdominal pain presented to us for CT examination of the abdomen. An ultrasound of the abdomen revealed lymphadenopathy at the porta hepatis, peripancreatic and retroperitoneal regions.

Contrast-enhanced CT examination was performed through the abdomen, from the domes of the diaphragm to the pubic symphysis. The examination revealed multiple, well-defined, oval to round, soft tissue attenuating masses in the liver, porta hepatis, peripancreatic region and retroperitoneum. In addition, a similar lesion was noted in the right lateral abdominal wall [Figure - 1]. The lesions were hypodense on non-contrast images with minimal to mild heterogeneous enhancement on post-contrast images. No other abnormality was noted. Radiological probability of neurofibromas was suggested, which was confirmed by histopathological diagnosis [Figure - 2].

This patient was managed conservatively on medical therapy and followed up for 3-4 months, during which the patient did well. Patient was suggested to follow up at six-monthly intervals.

Case 2

A 43-year-old male patient came for CT examination of the abdomen with complaints of recurrent vomiting and occasional hemetemesis, and abdominal distension especially after meals. An ultrasound of the abdomen was unremarkable.

Contrast-enhanced CT examination was performed through the abdomen, from the domes of the diaphragm to the pubic symphysis. The examination revealed a large, well-defined, polypoidal soft tissue mass with mild to moderate post-contrast enhancement along the greater curvature of the stomach. In addition, diffuse thickening of gastric wall in the region of the pyloric antrum was observed with over-distension of the stomach suggesting gastric outlet obstruction [Figure - 3]. Post-contrast enhancement of the thickened wall was insignificant. No associated lymphadenopathy was noted. As the patient was a case of NF1, the radiological possibility of gastric neurofibroma with gastric outlet obstruction possibly due to submucosal neurofibroma was suggested. However, the possibility of gastric adenocarcinoma was not ruled out. Endoscopic biopsy and tissue diagnosis confirmed the polypoidal mass to be a neurofibroma, and the thickened wall to be submucosal neurofibromatosis.

The patient underwent partial gastrectomy along with Billroth type-II gastrojejunostomy. The post-operative as well as the 6-month follow-up period was uneventful.


   Discussion Top


NF1 is a multisystemic disorder that may affect any organ in the body. Clinical presentation depends on the organ system involved. In NF1, gastrointestinal tumors occur most frequently followed by thoracic tumors, arterial involvement and endocrine tumors in the decreasing order of their frequency. [1],[2] Abdominopelvic involvement in NF1 is primarily extraperitoneal. Although lesions are mostly detected in the abdominopelvic wall and lumbosacral plexus, retroperitoneal and pelvic involvement is more common and usually affects important organs. [3] GI tract involvement includes neurofibromas within the liver, mesentery, retroperitoneum, stomach, small and large bowel, rectum, small-bowel leiomyomas, small-bowel adenocarcinoma with neuroendocrine function, GI tract vasculopathy and bleeding, pseudo-obstruction and protein-losing enteropathy. Patients may present with abdominal pain, nausea, abdominal distension, diarrhea, constipation, bowel perforation or GI tract bleeding.

In one study, majority of the neoplasms were located in the small intestine (72%). Neurofibromas, found in 52% of patients, were the most frequently diagnosed benign neoplasms followed by leiomyomas (13%), ganglioneurofibromas (9.8%) and gastrointestinal stromal tumor (6.5%). Adenocarcinoma was present in 23% of patients. Neurofibromas may be diffuse and submucosal, making radiographic visualization sometimes very difficult. Auerbach plexus is the usual site of origin. Benign neurofibromas undergo malignant transformation in 5-15%, especially in patients above the age of 40 years. [4]

Imaging plays an important role in the diagnosis, evaluation and follow-up of patients with abdominal manifestations of NF1. Barium studies may demonstrate intraluminal mass lesions. Sometimes, intussusception of the bowel may be detected along with intestinal obstruction. Features of malabsorption may also be seen.

Solitary neurofibroma is mostly hyperechoic with coarse internal echoes and is lobulated but with smooth and well-defined margins. Biliary obstruction may be demonstrated, and tumour metastasis into the liver along the portal vein may be seen as infiltrative hypoechoic masses around the porta hepatis and intrahepatic portal branches. Duplex color and spectral Doppler ultrasonography reveal the vascular complications of NF1 such as aneurysms and stenoses.

Biliary strictures and bile duct intraluminal neurofibromas are rarely associated with NF, but if present, may be visualized by antegrade or retrograde cholangiographic imaging.

CT examination may demonstrate solid fusiform masses along the distribution of nerves, with central areas of low attenuation and occasional calcification. The masses usually are well defined and have homogeneous low attenuation, equal to or slightly more than water, but lower than muscles. [5] Asymmetry in the size or attenuation of the mass may suggest malignant transformation. [6] They may also show mild to moderate heterogeneous post-contrast enhancement.

Magnetic resonance imaging (MRI) is considered to be the modality of choice. In one series, MR imaging added information in the initial and follow-up clinical evaluation of these patients. [3]

Surgical excision is the treatment of choice for all symptomatic tumours occurring in patients with NF1. As the benign tumours occurring in these patients always carry some risk of malignant degeneration, surgical excision of such tumours is advocated. [7] But as the risk of malignant degeneration and developing malignancy even after surgery cannot be calculated preoperatively, surgical excision of benign asymptomatic tumours is still controversial.

In conclusion, patients with NF1 with GI symptoms are at risk for GI neoplasms from which they are likely to experience significant morbidity. Due to its rarity, a high degree of suspicion is needed for timely diagnosis. Delay in the diagnosis of GI NF is common. The average interval from onset of GI symptoms to the diagnosis and detection of GI neoplasms was 2.8 years in one series. [4] Diagnosis may be difficult due to non-specific symptoms as well as the predominantly small bowel location. Imaging studies not only help in evaluation and localizing the lesions, but also help in identifying concomitant lesions and in the follow-up assessments of these patients.

 
   References Top

1.Wander JV, Das Gupta TK. Neurofibromatosis. Curr Probl Surg 1977;14:1-81.  Back to cited text no. 1    
2.Nordback P, Halkic N, Boumghar M. Intrathoracic tumors in von Recklinghausen's neurofibromatosis. Schweiz Med Wochenschr 2000;130:1105-11.  Back to cited text no. 2  [PUBMED]  
3.Zacharia TT, Jaramillo D, Poussaint TY, Korf B. MR imaging of abdominopelvic involvement in neurofibromatosis type 1: A review of 43 patients. Pediatr Radiol 2005;35:317-22.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Bakker JR, Haber MM, Garcia FU. Gastrointestinal neurofibromatosis: An unusual cause of gastric outlet obstruction. Am Surg 2005;71:100-5.  Back to cited text no. 4  [PUBMED]  
5.Lee JK, Hiken JN, Semelka RC. Retroperitoneum. In : Lee JK, Sagel SS, Stanley RJ, Heiken JP, editors. Computed body tomography. 3 rd ed. Lippincott-Raven: Philadelphia; 1998. p. 1074.  Back to cited text no. 5    
6.Bass JC, Korobkin M, Francis IR, Ellis JH, Cohan RH. Retroperitoneal plexiform neurofibromas: CT findings. AJR Am J Roentgenol 1994;163:617-20.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]
7.Cosgrove JM, Fischer MG. Gastrointestinal neurofibroma in a patient with von Recklinghausen's disease. Surgery 1988;103:701-3.  Back to cited text no. 7  [PUBMED]  

Top
Correspondence Address:
Rajul Rastogi
C-002, Upkari Apartments, Plot No 9, Sector 12, Dwarka, Delhi 110 078
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1319-3767.39623

Rights and Permissions


    Figures

  [Figure - 1], [Figure - 2], [Figure - 3]

This article has been cited by
1 Intestinal obstruction in von Recklinghausenćs disease
B. Trilling,J.-L. Faucheron
Colorectal Disease. 2014; 16(10): 762
[Pubmed] | [DOI]
2 Neurofibroma invading into urinary bladder presenting with symptoms of obstructed defecation and a large perineal hernia
Duminda Subasinghe,Chathuranga Keppetiyagama,Chandu De Silva,Neville D Perera,Dharmabandhu N Samarasekera
BMC Surgery. 2014; 14(1): 21
[Pubmed] | [DOI]
3 Gastrointestinal neurofibromatosis with malignant transformation: A case report
Binesh, F. and Akhavan, A. and Arefanian, S. and Haidari, M.
Chinese-German Journal of Clinical Oncology. 2013; 12(6): P297-P299
[Pubmed]
4 Gastrointestinal neurofibromatosis with malignant transformation: a case report
Fariba Binesh,Ali Akhavan,Saeed Arefanian,Manuchehr Haidari
The Chinese-German Journal of Clinical Oncology. 2013; 12(6): 297
[Pubmed] | [DOI]
5 Gastrointestinal bleeding secondary to intestinal neurofibromatosis
Selfa-Muñoz, A. and Ruiz-Escolano, E. and Martínez-Tirado, P. and del Pilar López-Segura, R. and Sáez-Zafra, A. and Salmerón-Escobar, F.J.
Revista Espanola de Enfermedades Digestivas. 2012; 104(2): 99-100
[Pubmed]
6 Gastrointestinal manifestation of recklinghausenćs disease [A recklinghausen-kĂłr enterális manifesztáciĂłja]
Hajdu, M. and Krutsay, M. and Chanis, W.
Magyar Onkologia. 2008; 52(4): 375-377
[Pubmed]
7 A Recklinghausen-kór enterális manifesztációja
Mária Hajdu,Miklós Krutsay,William Chanis
Magyar Onkológia. 2008; 52(4): 375
[Pubmed] | [DOI]



 

Top
 
  Search
 
  
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
    Case Reports
    Discussion
    References
    Article Figures

 Article Access Statistics
    Viewed9918    
    Printed140    
    Emailed6    
    PDF Downloaded630    
    Comments [Add]    
    Cited by others 7    

Recommend this journal